Treatment of Refractory Pityriasis Rubra Pilaris With Novel Phosphodiesterase 4 (PDE4) Inhibitor Apremilast

被引：22
|
作者：
Krase, Ifat Zerin [1 ]
Cavanaugh, Kevin [2 ]
Curiel-Lewandrowski, Clara [2 ]
机构：
[1] Univ Arizona, Coll Med, Tucson, AZ 85724 USA
[2] Univ Arizona, Dept Dermatol, 1501 N Campbell Ave, Tucson, AZ 85724 USA
来源：
JAMA DERMATOLOGY | 2016年 / 152卷 / 03期
关键词：
D O I：
10.1001/jamadermatol.2015.3405
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：348 / 350
页数：4
相关论文
共 50 条
  • [41] Antidepressant effects mediated by phosphodiesterase-4 (PDE4)
    ODonnell, J. M.
    BEHAVIOURAL PHARMACOLOGY, 2007, 18 : S8 - S8
  • [42] Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults
    Paller, Amy S.
    Tom, Wynnis L.
    Lebwohl, Mark G.
    Blumenthal, Robin L.
    Boguniewicz, Mark
    Call, Robert S.
    Eichenfield, Lawrence F.
    Forsha, Douglass W.
    Rees, William C.
    Simpson, Eric L.
    Spellman, Mary C.
    Gold, Linda F. Stein
    Zaenglein, Andrea L.
    Hughes, Matilda H.
    Zane, Lee T.
    Hebert, Adelaide A.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 75 (03) : 494 - +
  • [43] Erratum to: Apremilast: A Phosphodiesterase 4 Inhibitor for the Treatment of Psoriatic Arthritis
    Philip J. Mease
    Rheumatology and Therapy, 2015, 2 (1) : 97 - 97
  • [44] The effect and associated mechanism of action of phosphodiesterase 4 (PDE4) inhibitor on CD4+lymphocyte proliferation
    Kim, Shin Young
    An, Tai Joon
    Rhee, Chin Kook
    Park, Chan Kwon
    Kim, Ji Hye
    Yoon, HyoungKyu
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2021, 48 (02) : 221 - 226
  • [45] Novel PDE4 inhibitors
    Lloyd, A
    DRUG DISCOVERY TODAY, 2000, 5 (04) : 166 - 166
  • [46] THE EFFECT AND RELATED MECHANISM OF PHOSPHODIESTERASE 4 (PDE4) INHIBITOR ON CD4+T LYMPHOCYTE PROLIFERATION
    Kim, Shin Young
    Yoon, Hyoung Kyu
    Rhee, Chin Kook
    Kim, Seung Hoon
    RESPIROLOGY, 2018, 23 : 11 - 11
  • [47] Long-term ustekinumab treatment for refractory type I pityriasis rubra pilaris
    Di Stefani, Alessandro
    Galluzzo, Marco
    Talamonti, Marina
    Chiricozzi, Andrea
    Costanzo, Antonio
    Chimenti, Sergio
    JOURNAL OF DERMATOLOGICAL CASE REPORTS, 2013, 7 (01): : 5 - 9
  • [48] The PDE4 inhibitor, apremilast, suppresses experimentally induced alopecia areata in human skin in vivo
    Keren, Aviad
    Shemer, Avner
    Ullmann, Yehuda
    Paus, Ralf
    Gilhar, Amos
    JOURNAL OF DERMATOLOGICAL SCIENCE, 2015, 77 (01) : 74 - 76
  • [49] Antidepressant effects of inhibitors of cAMP phosphodiesterase (PDE4)
    O'Donnell, JM
    Zhang, HT
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2004, 25 (03) : 158 - 163
  • [50] Design and synthesis of novel indole-quinoxaline hybrids to target phosphodiesterase 4 (PDE4)
    Luther, Bethala Jawahar
    Rani, Chekuri Sharmila
    Suresh, Namburi
    Rao, Mandava V. Basaveswara
    Kapavarapu, Ravikumar
    Suresh, Chakali
    Babu, P. Vijaya
    Pal, Manojit
    ARABIAN JOURNAL OF CHEMISTRY, 2019, 12 (08) : 3108 - 3117
12345